Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...

The FDA has classified the recall as a Class II health risk. This classification is used when exposure to a product may cause temporary or medically reversible health consequences, or when the ...